Market News

Hikari Power LTD Has Trimmed By $740,000 Its Acadia Pharmaceuticals (ACAD) Holding; Last Week Flex Ltd. (FLEX) Analysts

Hikari Power Ltd decreased Acadia Pharmaceuticals Inc (ACAD) stake by 33.33% reported in 2017Q3 SEC filing. Hikari Power Ltd sold 20,000 shares as Acadia Pharmaceuticals Inc (ACAD)’s stock declined 29.10%. The Hikari Power Ltd holds 40,000 shares with $1.51M value, down from 60,000 last quarter. Acadia Pharmaceuticals Inc now has $3.76B valuation. The stock increased 2.59% or $0.77 during the last trading session, reaching $30.27. About 743,939 shares traded. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has declined 15.19% since February 14, 2017 and is downtrending. It has underperformed by 31.89% the S&P500.

Among 15 analysts covering Flextronics International Ltd. (NASDAQ:FLEX), 11 have Buy rating, 1 Sell and 3 Hold. Therefore 73% are positive. Flextronics International Ltd. had 48 analyst reports since July 28, 2015 according to SRatingsIntel. The rating was maintained by Bank of America on Thursday, May 12 with “Buy”. The rating was maintained by Needham with “Buy” on Tuesday, October 20. The rating was maintained by Stifel Nicolaus with “Buy” on Sunday, October 15. The stock of Flex Ltd. (NASDAQ:FLEX) has “Buy” rating given on Monday, July 24 by RBC Capital Markets. JP Morgan initiated the stock with “Overweight” rating in Tuesday, April 26 report. As per Wednesday, October 5, the company rating was maintained by Goldman Sachs. On Wednesday, August 30 the stock rating was maintained by Needham with “Buy”. Argus Research upgraded Flex Ltd. (NASDAQ:FLEX) rating on Friday, January 29. Argus Research has “Buy” rating and $13 target. The firm earned “Buy” rating on Friday, June 16 by RBC Capital Markets. On Friday, October 27 the stock rating was maintained by Needham with “Buy”. See Flex Ltd. (NASDAQ:FLEX) latest ratings:

25/01/2018 Broker: RBC Capital Markets Rating: Buy New Target: $22.0 Maintain
25/01/2018 Broker: Stifel Nicolaus Rating: Buy New Target: $22.0 Maintain
03/01/2018 Broker: RBC Capital Markets Rating: Buy New Target: $21.0 Maintain
19/12/2017 Broker: UBS Rating: Buy New Target: $21.5 Maintain
01/11/2017 Broker: Argus Research Rating: Buy Old Target: $20 New Target: $23 Maintain
27/10/2017 Broker: Needham Rating: Buy New Target: $19.0 Maintain
27/10/2017 Broker: UBS Rating: Buy Old Target: $18 New Target: $19.75 Maintain
27/10/2017 Broker: Citigroup Rating: Buy Old Target: $18 New Target: $20 Maintain
27/10/2017 Broker: Stifel Nicolaus Rating: Buy Old Target: $19 New Target: $20 Maintain
15/10/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $19.0 Maintain

Investors sentiment decreased to 1.01 in Q3 2017. Its down 0.04, from 1.05 in 2017Q2. It is negative, as 25 investors sold ACAD shares while 58 reduced holdings. 32 funds opened positions while 52 raised stakes. 113.55 million shares or 1.98% less from 115.85 million shares in 2017Q2 were reported. Franklin Res has 3.07 million shares. 4,427 were accumulated by San Francisco Sentry Group Inc (Ca). 813,300 are held by Tiaa Cref Management Ltd Company. Moreover, Ubs Asset Americas Inc has 0.03% invested in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Goldman Sachs Group Inc Inc Inc reported 0.02% of its portfolio in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Pennsylvania-based Riggs Asset Managment has invested 0.01% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Morgan Stanley invested 0% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Lpl Fincl Ltd Limited Liability Company holds 93,155 shares. Bnp Paribas Arbitrage has 0% invested in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Aqr Ltd Llc owns 38,660 shares or 0% of their US portfolio. Legal General Group Public Ltd reported 39,604 shares or 0% of all its holdings. Parallax Volatility Advisers Ltd Partnership has invested 0% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). 8,067 were accumulated by Teacher Retirement Of Texas. Family Management Corp invested in 29,500 shares or 0.76% of the stock. Knott David M accumulated 550 shares or 0.01% of the stock.

Since August 30, 2017, it had 0 insider buys, and 5 sales for $6.63 million activity. The insider Baity Glenn sold 26,507 shares worth $924,315. Brege Laura also sold $751,543 worth of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shares.

Analysts await ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to report earnings on February, 27. They expect $-0.58 EPS, up 10.77% or $0.07 from last year’s $-0.65 per share. After $-0.53 actual EPS reported by ACADIA Pharmaceuticals Inc. for the previous quarter, Wall Street now forecasts 9.43% negative EPS growth.

Among 12 analysts covering ACADIA Pharmaceuticals (NASDAQ:ACAD), 9 have Buy rating, 0 Sell and 3 Hold. Therefore 75% are positive. ACADIA Pharmaceuticals had 33 analyst reports since August 7, 2015 according to SRatingsIntel. The stock has “Buy” rating by Jefferies on Monday, June 26. As per Monday, September 4, the company rating was maintained by Jefferies. On Tuesday, October 10 the stock rating was maintained by Jefferies with “Buy”. The firm earned “Buy” rating on Friday, August 7 by Needham. H.C. Wainwright maintained ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) rating on Wednesday, August 9. H.C. Wainwright has “Buy” rating and $6000 target. As per Thursday, August 27, the company rating was upgraded by Piper Jaffray. Ladenburg Thalmann reinitiated it with “Buy” rating and $48 target in Thursday, February 2 report. Leerink Swann downgraded the stock to “Market Perform” rating in Tuesday, May 3 report. As per Friday, September 15, the company rating was maintained by Needham. On Monday, August 10 the stock rating was upgraded by Vetr to “Hold”.

Hikari Power Ltd increased Phillips 66 (NYSE:PSX) stake by 10,800 shares to 226,500 valued at $20.75 million in 2017Q3. It also upped Dynavax Technologies Corporation (NASDAQ:DVAX) stake by 25,000 shares and now owns 108,755 shares. Davita Healthcare Partners Inc (NYSE:DVA) was raised too.

Since August 15, 2017, it had 0 insider buys, and 1 insider sale for $243,573 activity. Tan Lay Koon also sold $43,457 worth of Flex Ltd. (NASDAQ:FLEX) on Tuesday, August 15. Another trade for 13,597 shares valued at $243,573 was made by SHIH WILLY C on Thursday, February 1.

Flex Ltd. provides design, engineering, manufacturing, and supply chain services and solutions to original equipment manufacturers worldwide. The company has market cap of $8.95 billion. It offers innovation services, such as innovations labs for supporting customer design and product development services from early concept stages; collective innovation platform, an ecosystem of technology solutions; Lab IX, a startup accelerator program; centers of excellence solutions in critical areas; interconnect technology center for printed circuits; and CloudLabs that enables clients to accelerate a spectrum of cloud, converged infrastructure, and datacenter strategies. It has a 16.83 P/E ratio. The firm also provides design and engineering services, including contract design and joint development manufacturing services, which cover various technical competencies, such as system architecture, user interface and industrial design, mechanical engineering, technology, enclosure systems, thermal and tooling design, electronic system design, reliability and failure analysis, and component level development engineering; and systems assembly and manufacturing services.

Leave a Reply

Your email address will not be published. Required fields are marked *